Premium
Pretherapeutic identification of high‐risk acute myeloid leukemia (AML) patients from immunophenotypic, cytogenetic, and clinical parameters
Author(s) -
Valet G.,
Repp R.,
Link H.,
Ehninger A.,
Gramatzki M M.
Publication year - 2003
Publication title -
cytometry part b: clinical cytometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.646
H-Index - 61
eISSN - 1552-4957
pISSN - 1552-4949
DOI - 10.1002/cyto.b.10028
Subject(s) - medicine , immunophenotyping , myeloid leukemia , cd33 , oncology , myeloid , cytogenetics , gastroenterology , leukemia , complete remission , flow cytometry , pathology , immunology , cd34 , chemotherapy , stem cell , biology , gene , biochemistry , chromosome , genetics
The goal of this study concerned the pretherapeutic identification of high-risk acute myeloid leukemia (AML) patients by data pattern analysis from flow cytometric immunophenotype, cytogenetic, and clinical data.